Developmental Funds

医疗基金：摘要 来自各种来源的发展资金（例如，CCSG、其他赞助研究、机构、州， 慈善事业等）使斯蒂芬森癌症中心（SCC）能够追求新的研究创新， 协作他们帮助推进SCC的总体使命和战略目标，并为以下方面提供支持 项目负责人，以实现有针对性的科学目标。发展基金支助的基本活动 包括：校内补助金计划、招聘新调查员、 调查员和新的共享资源开发。这些有助于推进SCC的核心战略优先事项： 1)提高癌症研究的广度、深度和影响力; 2）促进发现的转化 3）设计和进行假设驱动的试验，以改善 癌症患者或有癌症风险的人的成果; 4）促进方案内和方案间的合作， 跨学科团队科学; 5）加强COE以解决优先癌症和普遍存在的癌症问题 6）增加学生和教师的培训和指导机会;以及7） 加强少数民族和妇女在SCC领导层中的代表性不足， 会员资格和管道计划。关于发展资金分配的所有决定 最终由SCC主任负责，他每两周与中心的研究领导团队会面， 讨论新的研究机会和以校内赠款形式分配发展资金， 招聘，新技术投资和有针对性的资金，以追求新的战略驱动 举措 SCC利用通过校内赠款计划授予的发展资金， 研究，加强跨学科合作，支持职业发展，并解决优先癌症问题 以及SCC集水区普遍存在的癌症问题。在报告期内（CY 2017 -21），SCC 通过各种方案发放了85笔校内赠款，总金额为3 053 349美元。截至 12/31/21，这些赠款已导致71个同行审查的出版物和10 246 254美元（直接费用总额）， 校外赞助的研究经费值得注意的是，这85个中有21个是通过新的赠款计划获得的。 自2020年成立以来，它们刚刚完成第一个供资周期，仍在等待结果。在 此外，发展基金已被用于招募31名新的癌症为重点的研究人员到SCC（两者都 在过去的五年里，OUHSC和诺曼校区），大大提高了跨学科 专业知识和SCC的三个项目之间的团队科学的潜力。值得注意的是，其中五个（16%） 新招募的人员为URM个体，超过一半（n=16）为女性。

DEVELOPMENTAL FUNDS: ABSTRACT Developmental funds from a variety of sources (e.g., CCSG, other sponsored research, institution, state, philanthropy, etc.) enable the Stephenson Cancer Center (SCC) to pursue new research innovation and collaboration. They help advance the SCC’s overall mission and strategic goals as well as provide support for program leaders to achieve targeted scientific goals. Essential activities supported by developmental funds include: intramural grant programs, recruitment of new investigators, career development for early-stage investigators, and new shared resource development. These help advance the SCC’s core strategic priorities: 1) enhancing breadth, depth and impact of cancer-focused research; 2) fostering the translation of discoveries into the clinical or community setting; 3) designing and conducting hypothesis-driven trials to improve outcomes for people with or at risk for cancer; 4) promoting intra- and inter-programmatic collaboration and transdisciplinary team science; 5) enhancing COE to address priority cancers and cancer problems prevalent in the SCC catchment area; 6) increasing training and mentorship opportunities for students and faculty; and 7) enhancing the presence of underrepresented minority (URM) persons and women among SCC leadership and membership, and in pipeline programs. All decisions concerning the allocation of developmental funds ultimately rest with the SCC director, who meets with the center’s research leadership team biweekly to discuss new research opportunities and allocation of developmental funds in the form of intramural grants, recruitment, investments in new technologies, and targeted funding to pursue new strategically driven initiatives. The SCC has utilized developmental funds awarded through intramural grant programs to stimulate new research, enhance transdisciplinary collaboration, support career development, and address priority cancers and cancer problems prevalent in the SCC catchment area. During the reporting period (CY2017-21), the SCC awarded 85 intramural grants through a variety of programs, with a total award amount of $3,053,349. As of 12/31/21, these grants have resulted in 71 peer-reviewed publications and $10,246,254 (total, direct cost) in extramural sponsored research funding. Notably, 21 of these 85 were awarded through grant programs newly established since 2020; thus, they are just completing first funding cycles and are still pending outcomes. In addition, developmental funds have been used to recruit 31 new cancer-focused investigators to the SCC (both the OUHSC and OU Norman campuses) over the past five years, significantly enhancing transdisciplinary expertise and the potential for team science among the SCC’s three programs. Notably, five (16%) of these new recruits are URM individuals and more than half (n=16) are female.